SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-05-002011
Filing Date
2005-08-15
Accepted
2005-08-15 11:48:46
Documents
2
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 6/30/05 sks187a.htm 6-K 403257
2 GRAPHIC nymox.gif GRAPHIC 2528
  Complete submission text file 0000897069-05-002011.txt   408327
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 051024377
SIC: 2835 In Vitro & In Vivo Diagnostic Substances